Japan discovers potential treatment of autoimmune diseases

Scientists in Japan have revealed a chemical compound that could be used for the treatment of various autoimmune disease...

March 7, 2023 | Tuesday | News
European Union approves first gene therapy for hemophilia B

Australian biotechnology leader CSL has announced that the European Commission has granted conditional marketing authori...

February 23, 2023 | Thursday | News
Korean firms to develop novel microbiome treatment for Parkinson's disease

South Korean startup LISCure Biosciences Inc. has announced a multi-year strategic R&D collaboration with Celltrion ...

February 21, 2023 | Tuesday | News
New Zealand approves globally regarded soft-tissue sarcoma therapy

Singapore-headquartered biopharmaceutical company Specialised Therapeutics (ST) has announced that its portfolio therapy...

February 17, 2023 | Friday | News
Australia discovers receptor that blocks COVID-19 infection

Australia's University of Sydney scientists have discovered a protein in the lung that blocks SARS-CoV-2 infection and f...

February 14, 2023 | Tuesday | News
Japan develops method to design new peptide therapeutics for combating antibiotic resistance

Applications of new molecules as drugs are expected to be effective in treating diseases that are difficult to cure with...

February 13, 2023 | Monday | News
“We need to foster risky projects that can have large rewards”

What is Anticancer Bioscience’s  competitive edge and what is unique about the pipeline you are developing?&n...

February 7, 2023 | Tuesday | Opinion
Singapore is beginning to see benefits of investing in technological aspect of cancer treatment

Medicine and technology have made tremendous strides toward defeating one of the deadliest diseases of the world, despit...

February 6, 2023 | Monday | Opinion
Singapore explores regenerative therapy to restore impaired kidney function

In a world first, scientists at Duke-NUS Medical School, the National Heart Centre Singapore (NHCS) and colleagues in ...

February 3, 2023 | Friday | News
New trial in Australia uses cannabis for spinal cord injury induced chronic pain

Scientists at the University of Sydney, Australia have been awarded $1.7 million from New South Wales Ministry ...

January 30, 2023 | Monday | News
Researchers at Chula Medicine in Thailand explain detection of latent dementia

According to the scientists at Thai Red Cross Emerging Infectious Diseases Health Science Center, Faculty of Medicine,&n...

January 30, 2023 | Monday | News
Scientists in New Zealand identify drug that could extend lifespan

The age-old quest for immortality has taken a step forward with the results of a New Zealand study recently published by...

January 27, 2023 | Friday | News
Korea's GenKOre inks $300 M deal with US to develop in vivo gene-editing therapies

GenKOre, Inc., a Korea-based biotech company with hypercompact CRISPR-Cas tools, has entered into a ...

January 26, 2023 | Thursday | News
China-based startup ReLive Biotechnologies strengthens presence in regenerative therapy market

ReLive Biotechnologies, founded in 2021, has completed the acquisition of all operating assets of Germany-listed bi...

January 26, 2023 | Thursday | News
Australian biotech startup Ferronova secures A$11 M to advance nanotech image-guided cancer therapy

Ferronova has secured a further A$11 million to progress the company's nanoparticle platform to assist surgeon...

January 23, 2023 | Monday | News
Japan's Kaneka expands GMP manufacturing capacity for mRNA to Europe

Tokyo Headquarterd Kaneka Corporation is set to increase its GMP manufacturing capacity for mRNA in ...

January 19, 2023 | Thursday | News
Hong Kong to emerge as technology hub for microbiome industry in APAC region

The Faculty of Medicine of The Chinese University of Hong Kong (CU Medicine), Microbiota I-Center (MagIC), and Hong Kong...

January 18, 2023 | Wednesday | News
Australia turns back the clock on damaged heart tissue

After a heart attack, the shock of the event leaves behind a trail of damaged heart muscle, which becomes a scar over ti...

January 17, 2023 | Tuesday | News
"Global investors can leverage our deep immunomics platform to develop TCR Cell therapies for solid tumours"

How crucial is the adaptation of next-generation TCR cell therapies for diagnostic and prophylactic purposes? TCR cell ...

January 16, 2023 | Monday | Opinion
Australia's Monash University inks research collaboration with Japan-based Ono Pharma

An option and research collaboration agreement has been established between Australia's Monash University and Japan-base...

January 13, 2023 | Friday | News
Malaysian Genomics explores R&D collaboration with SIRIM

Malaysian Genomics Resource Centre Berhad , a leading genomics and biopharmaceutical specialist,  has announced a s...

January 10, 2023 | Tuesday | News
First made-in-Singapore antibody-drug conjugate to enter clinical trials

Singapore’s drug discovery efforts have reached a new milestone as EBC-129, the first made-in-Singapore antibody-d...

January 9, 2023 | Monday | News
“We are seeing activity within biotherapeutics market in Southeast Asia”

With biomarkers and biotherapeutics gaining significant attention in 2022, BioSpectrum spoke in detail with Jason Neo (R...

January 6, 2023 | Friday | Opinion
US explores application of 3D bioprinting to create eye tissue

Scientists are now using patient stem cells and 3D bioprinting to produce eye tissue that will advance understanding of ...

December 26, 2022 | Monday | News
Australian first research trial to explore use of psychedelics for alcohol use disorder

Researchers at the University of Sydney are embarking on an Australian first research trial into the use of psychedeli...

December 22, 2022 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls